ir.eigerbio.com ir.eigerbio.com

ir.eigerbio.com

Investor Overview - Investor Relations - EigerBio

A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. 8th Annual Piper Jaffray Healthcare Conference. Lotte NY Palace Hotel. November 30, 2016. Click here to listen to the webcast. Investor News and Events. As obesity a...

http://ir.eigerbio.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.EIGERBIO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 15 reviews
5 star
6
4 star
3
3 star
4
2 star
0
1 star
2

Hey there! Start your review of ir.eigerbio.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.4 seconds

CONTACTS AT IR.EIGERBIO.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Overview - Investor Relations - EigerBio | ir.eigerbio.com Reviews
<META>
DESCRIPTION
A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. 8th Annual Piper Jaffray Healthcare Conference. Lotte NY Palace Hotel. November 30, 2016. Click here to listen to the webcast. Investor News and Events. As obesity a...
<META>
KEYWORDS
1 click to print
2 conquering rare diseases
3 menu
4 about eiger
5 eiger biopharmaceuticals
6 management team
7 board of directors
8 scientific advisors
9 corporate presentation
10 phone
CONTENT
Page content here
KEYWORDS ON
PAGE
click to print,conquering rare diseases,menu,about eiger,eiger biopharmaceuticals,management team,board of directors,scientific advisors,corporate presentation,phone,email,info@eigerbio com,pipeline,eiger pipeline,news,news and events,press releases,price
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Overview - Investor Relations - EigerBio | ir.eigerbio.com Reviews

https://ir.eigerbio.com

A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. 8th Annual Piper Jaffray Healthcare Conference. Lotte NY Palace Hotel. November 30, 2016. Click here to listen to the webcast. Investor News and Events. As obesity a...

LINKS TO THIS WEBSITE

eigerbio.com eigerbio.com

The Lancet Publishes Results of Phase 2 Study of Lonafarnib in HDV Infected Patients - EigerBio

http://www.eigerbio.com/the-lancet-infectious-diseases-journal-publishes-results-of-phase-2-study-of-lonafarnib-in-hepatitis-delta-virus-hdv-infected-patients

The Lancet Publishes Results of Phase 2 Study of Lonafarnib in HDV Infected Patients - EigerBio. A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. Click Here for Webcast Link. As obesity an...

eigerbio.com eigerbio.com

Eiger Bio Receives Orphan Designation for Lonafarnib, a First In Class, Investigational Treatment for HDV Infection - EigerBio

http://www.eigerbio.com/press-release-2-december-22-2014

Eiger Bio Receives Orphan Designation for Lonafarnib, a First In Class, Investigational Treatment for HDV Infection - EigerBio. A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. As obesity ...

eigerbio.com eigerbio.com

Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) - EigerBio

http://www.eigerbio.com/eiger-bio-announces-interim-results-of-lonafarnib-in-combination-with-ritonavir-or-pegylated-interferon-in-patients-infected-with-hepatitis-delta-virus-hdv

Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) - EigerBio. A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. July 12, 2016 at 9am EST. As obesity and...

eigerbio.com eigerbio.com

Management Team - EigerBio

http://www.eigerbio.com/about-eiger/management-team

Management Team - EigerBio. A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. Click Here for Webcast Link. Click here to view the most recent and past press releases. As obesity and type II...

eigerbio.com eigerbio.com

Careers - EigerBio

http://www.eigerbio.com/careers

A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. Click Here for Webcast Link. Click here to view the most recent and past press releases. Investor News and Events. LOWR HDV 3 Duration Study.

eigerbio.com eigerbio.com

Board of Directors - EigerBio

http://www.eigerbio.com/about-eiger/board-of-directors

Board of Directors - EigerBio. A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. Click Here for Webcast Link. Click here to view the most recent and past press releases. As obesity and type...

eigerbio.com eigerbio.com

Staff Announcement April 14, 2015 - EigerBio

http://www.eigerbio.com/staff-announcement-april-14-2015

Staff Announcement April 14, 2015 - EigerBio. A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. Click Here for Webcast Link. Click here to view the most recent and past press releases.

eigerbio.com eigerbio.com

lonafarnib - EigerBio

http://www.eigerbio.com/pipeline/lonafarnib

A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. Click Here for Webcast Link. Click here to view the most recent and past press releases. Investor News and Events. LOWR HDV 3 Duration Study.

eigerbio.com eigerbio.com

Corporate Overview - EigerBio

http://www.eigerbio.com/about-eiger/corporate-overview

Corporate Overview - EigerBio. A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. July 12, 2016 at 9am EST. Click Here for Webcast Link. Click here to view the most recent and past press releases. As obesity and type...

UPGRADE TO PREMIUM TO VIEW 11 MORE

TOTAL LINKS TO THIS WEBSITE

20

OTHER SITES

ir.egytrans.com ir.egytrans.com

** EGYTRANS ** Integrated Global Transport Services & Solutions

Egyptian Transport and Commercial Services Co., S.A.E. Vision, mission, values. Financial Statements and Reports. CG Code, Structure and Policies. Chairman and CEO Duality. The Egyptian Transport and Commercial Services Company S.A.E. was established in December 1973 under Egypt’s open door policy with regard to private enterprises. However, its transport activities and experience date back to 1939 as a continuation to GAMAL EL DIN LEHETA and CO. Read more about us. Vision, mission, values.

ir.ehealthinsurance.com ir.ehealthinsurance.com

eHealthInsurance.com Investor Relations – IR Home - eHealth Insurance

EHealthInsurance.com Investor Relations â IR Home. Q2 2015 EHEALTH INC Earnings Conference Call. 160;at 5:00 pm ET. EHEALTH INC at Needham Interconnect Conference. 160;at 8:00 am ET. 160; 0.25. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Sign up to receive e-mail alerts whenever EHEALTH INC posts new information to the site. Just enter your e-mail address and click Submit. EHealth, Inc. is the parent company of eHealthInsurance Services Inc., the leading online source of health ins...

ir.ehousechina.com ir.ehousechina.com

E-House (China) Holdings Limited - IR Home

Q1 2015 Earnings Release. E-House Special Committee Engages Financial Advisor and Legal Counsel. SINA Joins Buyer Consortium in E-House's Proposed "Going Private" Transaction, to Become Leju Shareholder. E-House Announces Receipt of Preliminary Non-Binding "Going Private" Proposal. E-House Reports First Quarter 2015 Results. There are currently no events scheduled. Financial Reports - Quarterly and Other Reports. Data collected 08/01/15 - 08/08/15. 160; 0.08. Data as of 08/07/15 4:00 pm ET.

ir.eia.doe.gov ir.eia.doe.gov

Energy Information Administration - EIA's Information Releases website.

Welcome to EIA's Information Releases website. This website is dedicated to the data release of the Weekly Natural Gas Storage Report (WNGSR) and the data files associated with the 10:30 am release of the Weekly Petroleum Status Report (WPSR). On February 22, 2010, this website will be the official web location for the data files associated with the 10:30 release of the above products. Weekly Petroleum Status Report. Weekly Natural Gas Storage Report.

ir.eia.gov ir.eia.gov

Energy Information Administration - EIA's Information Releases website.

Welcome to EIA's Information Releases website. This website is dedicated to the data release of the Weekly Natural Gas Storage Report (WNGSR) and the data files associated with the 10:30 am release of the Weekly Petroleum Status Report (WPSR). On February 22, 2010, this website will be the official web location for the data files associated with the 10:30 release of the above products. Weekly Petroleum Status Report. Weekly Natural Gas Storage Report.

ir.eigerbio.com ir.eigerbio.com

Investor Overview - Investor Relations - EigerBio

A Biopharmaceutical Company Developing a Diverse Portfolio of Well-Characterized Drugs for Orphan Diseases. Eiger BioPharmaceuticals, Inc. 350 Cambridge Ave, Suite 350. Palo Alto, CA 94306. Click Here for Directions. Click each therapeutic area on the pipeline to the right to see more information. Click Here to See a Larger Pipeline Graphic. 8th Annual Piper Jaffray Healthcare Conference. Lotte NY Palace Hotel. November 30, 2016. Click here to listen to the webcast. Investor News and Events. As obesity a...

ir.ekornes.com ir.ekornes.com

Ekornes investor relations

Show current Stock Prices, and for the past 3, 6 and 12 months. Annual report 2017 (English). 1st Quarter Result 2018. Presentation of 1st Quarter Result 2018, with Webcast. 2nd Quarter Result 2018. Thursday, March 22, 2018. General Meeting of Ekornes ASA. Ekornes Bua, Brunholmgt. 8, Ålesund. Tuesday 24 April 2018 at 4.30pm.

ir.eku.edu ir.eku.edu

Office Of Institutional Research | Office Of Institutional Research | Eastern Kentucky University

Skip to main content. Office of Institutional Research. A to Z Index. A - Z Index. Office of Institutional Effectiveness. SAM (Student Achievement Measure). Office of Institutional Research. CPO 36 A, Coates 201. Richmond, KY 40475. Office of Institutional Research. What does IR do? We collect, analyze, and interpret institutional data to provide information for planning, policy formation and decision-making within the university. What services do we provide? How do I contact IR?

ir.elbitsystems.com ir.elbitsystems.com

Elbit - Investor Relations -Investor Relations Home

POB 539, Haifa 31053. Listen to Elbit Systems Ltd. Second Quarter 2015 Results Release. Conference Call Scheduled for for for August 11, 2015 at 9:00am ET. Elbit Systems of America Announces Continued Support of STEM Education. Elbit Systems Awarded an Approximately $45 Million Contract for the Supply of Military Communications Systems to a European Country. Elbit Systems Awarded Contracts to Supply DIRCM Self-Protection Systems for European and Asian Customers. This calendar contains six months of past ...

ir.eldoradoresorts.com ir.eldoradoresorts.com

Investors | Eldorado Resorts

Eldorado Resorts Inc. (NASDAQ: ERI) is a casino entertainment company that owns and operates seven properties in five states including: Eldorado Resort Casino, Silver Legacy Resort Casino, and Circus Circus Hotel Casino in Reno, NV; Eldorado Resort Casino in Shreveport, LA; Mountaineer Casino Racetrack and Resort in Chester, WV; Eldorado Gaming Scioto Downs in Columbus, OH; and Presque Isle Downs and Casino in Erie, PA. Gary Carano, Chairman and CEO. 25 People to Watch. As of 01/11/2017 Close.

ir.eleco.com ir.eleco.com

Home - Elecosoft plc - 5D BIM Software and Services for Architecture, Engineering and Construction

View Annual Report and Accounts 2015. Getting to the AGM. Half Year Results 2015. View Interim Report 2015. 5D BIM SOFTWARE AND SERVICES FOR THE ARCHITECTURAL, ENGINEERING AND CONSTRUCTION INDUSTRIES. In 1901, ELECO designed and supplied the electric light lanterns that now grace the Victoria Embankment in London and has provided innovative technical solutions to the UK construction industry for more than 100 years. in 2015 the name changed to Elecosoft and the company has now emerged as a leading su...